1. Home
  2. PRLD vs BEST Comparison

PRLD vs BEST Comparison

Compare PRLD & BEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • BEST
  • Stock Information
  • Founded
  • PRLD 2016
  • BEST 2007
  • Country
  • PRLD United States
  • BEST China
  • Employees
  • PRLD N/A
  • BEST N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • BEST
  • Sector
  • PRLD Health Care
  • BEST
  • Exchange
  • PRLD Nasdaq
  • BEST Nasdaq
  • Market Cap
  • PRLD 63.3M
  • BEST 54.0M
  • IPO Year
  • PRLD 2020
  • BEST N/A
  • Fundamental
  • Price
  • PRLD $1.04
  • BEST $2.69
  • Analyst Decision
  • PRLD Buy
  • BEST
  • Analyst Count
  • PRLD 3
  • BEST 0
  • Target Price
  • PRLD $5.33
  • BEST N/A
  • AVG Volume (30 Days)
  • PRLD 408.0K
  • BEST 11.4K
  • Earning Date
  • PRLD 11-06-2024
  • BEST 11-29-2024
  • Dividend Yield
  • PRLD N/A
  • BEST N/A
  • EPS Growth
  • PRLD N/A
  • BEST N/A
  • EPS
  • PRLD N/A
  • BEST N/A
  • Revenue
  • PRLD $3,000,000.00
  • BEST $1,183,106,017.00
  • Revenue This Year
  • PRLD N/A
  • BEST N/A
  • Revenue Next Year
  • PRLD N/A
  • BEST N/A
  • P/E Ratio
  • PRLD N/A
  • BEST N/A
  • Revenue Growth
  • PRLD N/A
  • BEST 11.57
  • 52 Week Low
  • PRLD $1.00
  • BEST $1.85
  • 52 Week High
  • PRLD $6.80
  • BEST $2.77
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 21.69
  • BEST 39.37
  • Support Level
  • PRLD $1.14
  • BEST $2.68
  • Resistance Level
  • PRLD $1.36
  • BEST $2.69
  • Average True Range (ATR)
  • PRLD 0.11
  • BEST 0.02
  • MACD
  • PRLD 0.03
  • BEST -0.00
  • Stochastic Oscillator
  • PRLD 7.53
  • BEST 12.19

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About BEST BEST Inc. each representing twenty (20)

BEST Inc is a supply chain company. It provides a New Retail platform that offers technology-enabled integrated solutions such as supply chain management, express delivery, freight, merchandise sourcing, cross-border supply chain, last-mile, financial and value-added services. The Group operates in the following operating segments, Supply chain management services, Freight, Global and Others. The Others category principally relates to cross-border logistic coordination services. The majority of revenue generated from Freight segment.

Share on Social Networks: